Navigation Links
Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
Date:6/25/2008

Alexandria, Va. The International Association for Dental Research (IADR) has selected Dr. Stuart Fischman, Professor of Oral Diagnostic Sciences (Emeritus) at the School of Dental Medicine, at the State University of New York, Buffalo, as the 2008 recipient of the Pharmacology/Therapeutics/Toxicology Research Award. The award will be presented at the IADR 86th General Session & Exhibition in Toronto, ON, Canada on July 2, 2008.

Dr. Fischman has made significant contributions to the evaluation of drugs used to prevent and treat the two most common diseases seen in dental practice - dental caries and periodontal diseases. The design and analysis of clinical trials of agents designed to prevent dental caries, calculus formation, and gingivitis complemented his activities in oral pathology and oral medicine. He designed and managed the studies, but also published many guidelines to aid colleagues in conducting such studies. His research studies, numbering more than 100, have evaluated a number of chemical agents for their ability to prevent calculus formation, reduce plaque accumulation, and prevent or reduce gingivitis. Several publications and presentations reviewed the various methodologies and indices, to provide "benchmarks" for colleagues. These publications continue to be widely cited in reviews and clinical trials.

Dr. Fischman has served the American Association for Dental Research (AADR) as a member of the Ethics Committee. This committee has made several recommendations to ensure that clinical trials are conducted in a professionally responsible manner. Dr. Fischman was a "founding member" of the IADR Pharmacology/Therapeutics/Toxicology Scientific Group. He served the Group as officer, rising through the ranks from "Member at Large" in 1979 to President in 1991. Although officially "retiring" in 1997, he remains very active in dental professional activities.

Supported by Wyeth Consumer Healthcare, the Pharmacology/Therapeutics/Toxicology Research Award is one of the 16 IADR Distinguished Scientist Awards and is one of the highest honors bestowed by the IADR. The Award is made for outstanding and sustained peer-reviewed research that has contributed to our knowledge of the mechanisms, efficacy, or safety of drugs used in dentistry and consists of a cash prize and a plaque.


'/>"/>

Contact: Linda Hemphill
lhemphill@iadr.org
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. Atchison receives Behavioral, Epidemiological and Health Services Research Award
2. Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter
3. Ukraines First Lady Kateryna Yushchenko Receives Inaugural MaxWell International Public Health Award
4. Tasker Products Receives USDA Authorization to Begin Commercialization of its Post-Chill Spray Application
5. Advertising Hall of Famer Charles D. Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy
6. Findley Davies Receives IABC Vision Awards
7. NeoMend Receives FDA Panels Recommendation for Approval of ProGEL(TM) Surgical Sealant
8. Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binsons, Northwood
9. DATATRAK International, Inc. Receives Notice From Nasdaq
10. AutoGenomics Receives a Key European Patent for HPV Detection
11. Rutgers scientist receives prestigious Young Investigator Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... ... 20, 2017 , ... International Protein, a company based out of Australia that ... the January ECRM trade show in Hilton Head, SC. , International Protein was ... create a line of products that would elevate her fitness regime. At this ECRM ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a ... has set out for each of his children. “The Angel” is the creation of ... Music in New York City, and impassioned writer. , When asked of her new ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, Case ... successful education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
(Date:1/19/2017)... England , January 19, 2017 ... and Otsuka in the Milner Therapeutics Consortium   ... scientists in Cambridge   ... (NYSE: PFE ) as a partner to ... the Consortium, which enables the efficient transfer of materials ...
(Date:1/19/2017)... 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... care is $2 5 billion global ... Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced ... Equipos Médicos S.A.S. (TeckMedica) in Colombia for the Company,s ...
Breaking Medicine Technology: